Bethany Sampsell
Adult Health · York, PANPI 1497189500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $599 and has fallen 76.5% since, to $141 in 2024.
Across 48 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$249
- GSK$133
- Astellas Pharma US Inc$104
- Ironshore Pharmaceuticals Inc.$74
- Alkermes, Inc.$64
- Novo Nordisk$61
- plus $396 from 17 others
What the payments were for
- Food & beverage$99592%
- Education$858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $249 |
| GSK | 7 | $133 |
| Astellas Pharma US Inc | 2 | $104 |
| Ironshore Pharmaceuticals Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $64 |
| Novo Nordisk | 4 | $61 |
| Amarin Pharma, Inc. | 3 | $53 |
| AbbVie | 2 | $42 |
| Lundbeck LLC | 2 | $36 |
| Pfizer | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Novartis | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$125
How this compares
$1,080 in reported general payments places this provider in the 70th percentile of 899 adult health providers in Pennsylvania.
Other adult health in York
- Beth SandyPhiladelphia$924K
- Jennifer MondilloSchwenksville$396K
- Diane NewmanPhiladelphia$343K
- Elizabeth FaustDouglassville$342K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
- Catherine HoldsworthPhiladelphia$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.